BiotechTube
Home/Opko Health/Steven D. Rubin
SD

Steven D. Rubin

Executive Vice President and Chief Financial Officer

Opko Health

Therapeutic Areas

EndocrinologyNephrologyOncologyInfectious Diseases

Opko Health Pipeline

DrugIndicationPhase
NGENLA™ (somatrogon)Pediatric Growth Hormone DeficiencyMarket
RAYALDEE® (calcifediol)Secondary Hyperparathyroidism in CKDMarket
MDX2004Advanced CancersPhase 1
Multispecific Antibodies (with Regeneron)Select Therapeutic IndicationsResearch
Oral Long-Acting PTH TabletHypoparathyroidismPreclinical
Nanoparticle VaccinesInfectious DiseasesResearch

Leadership Team at Opko Health

PF
Phillip Frost, M.D.
Chairman and Chief Executive Officer
JH
Jane H. Hsiao, Ph.D., MBA
Vice Chairman and Chief Technical Officer
EA
Elias A. Zerhouni, M.D.
Scientific Advisor (Former Director, NIH)
View full Opko Health profile